Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDoric Nimrod 3 Regulatory News (DNA3)

  • There is currently no data for DNA3

MSN 133 REDELIVERY CONDITION

28 Mar 2024 09:22

RNS Number : 5744I
Doric Nimrod Air Three Limited
28 March 2024
 

This announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 which forms part of domestic law in the United Kingdom pursuant to The European Union Withdrawal Act 2018, as amended by The Market Abuse (Amendment) (EU Exit) Regulations 2019.

 

28 March 2024

 

DORIC NIMROD AIR THREE LIMITED

 

ASSET UPDATE: REDELIVERY CONDITION SIDE LETTER

 

Overview

Doric Nimrod Air Three Limited (LSE:DNA3, LEI: 213800BMYMCBKT5W8M49) (the "Company") is a Guernsey domiciled company with shares admitted to trading on the Specialist Fund Segment of the London Stock Exchange's Main Market.

 

MSN133 Redelivery Condition Side Letter

The Company, via its wholly owned subsidiary DNA Alpha Limited (the "Subsidiary") has received notice from Emirates that it is exercising the option to enable it to redeliver the Airbus A380-861 aircraft bearing manufacturer's serial number 133 (registration A6-EEL, the "Aircraft") in the minimum condition equivalent to "half-life" together with a cash sum, as opposed to delivery in full-life condition. In the event the Aircraft is returned to the Subsidiary, Emirates will pay the sum of USD 12,000,000 to the Subsidiary, in addition to the normal monetary compensation arrangements, on or prior to the lease expiry date. The lease expiry date for the Aircraft, bearing manufacturer's serial number 133 (registration A6-EEL), is 27 November 2025.

 

The Board notes that the above does not preclude the Company from considering lease extension, sale or re-lease options for the Aircraft with Emirates or other counterparties.

 

This announcement has been released by JTC Fund Solutions (Guernsey) Limited, Company Secretary on behalf of the Company.

 

For further information, please contact:

 

For administrative and company information:

 

JTC Fund Solutions (Guernsey) Limited

+44 (0) 1481 702400

 

For shareholder information:

 

Nimrod Capital LLP

+44 (0) 20 7382 4565

 

 

END OF ANNOUNCEMENT

 

E&OE - in transmission

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRGCGDXBDDDGSI
Date   Source Headline
4th Apr 20237:00 amRNSDirectorate Change
15th Feb 20237:00 amRNSChange in Board and Board Committee Composition
13th Jan 20234:58 pmRNSQuarterly Report
12th Jan 20235:26 pmRNSDividend Declaration
15th Dec 20225:25 pmRNSHalf-year Report
13th Dec 20229:34 amRNSDirector Declaration
12th Dec 202212:09 pmRNSResult of AGM
15th Nov 20224:45 pmRNSNotice of AGM
13th Oct 20225:21 pmRNSQuarterly Report
13th Oct 20225:19 pmRNSDividend Declaration
23rd Sep 20223:10 pmRNSHolding(s) in Company
22nd Sep 20224:32 pmRNSHolding(s) in Company
8th Aug 20225:12 pmRNSHolding(s) in Company
29th Jul 20226:26 pmRNSAnnual Financial Report
15th Jul 20223:27 pmRNSQuarterly Report
14th Jul 20224:26 pmRNSDividend Declaration
12th Apr 20224:58 pmRNSQuarterly Report
12th Apr 20224:49 pmRNSDividend Declaration
1st Mar 20222:34 pmRNSDirectorate Change
13th Jan 20225:05 pmRNSQuarterly Report
13th Jan 20225:05 pmRNSDividend Declaration
21st Dec 202112:55 pmRNSDirectorate Change
16th Dec 20215:03 pmRNSHalf-year Report
9th Dec 20216:05 pmRNSResult of AGM
27th Oct 20211:14 pmRNSNotice of AGM
14th Oct 20214:00 pmRNSQuarterly Report
14th Oct 20214:00 pmRNSDividend Declaration
1st Oct 20217:00 amRNSHolding(s) in Company
12th Aug 20215:30 pmRNSAnnual Financial Report - Correction
2nd Aug 20216:34 pmRNSAnnual Financial Report
28th Jul 20214:27 pmRNSHolding(s) in Company
15th Jul 20211:50 pmRNSQuarterly Report
15th Jul 20211:50 pmRNSDividend Declaration
16th Apr 20214:41 pmRNSSecond Price Monitoring Extn
16th Apr 20214:36 pmRNSPrice Monitoring Extension
15th Apr 20213:30 pmRNSQuarterly Report
15th Apr 20213:30 pmRNSDividend Declaration
14th Jan 20215:00 pmRNSQuarterly Report
14th Jan 20215:00 pmRNSDividend Declaration
10th Dec 20205:36 pmRNSResult of AGM
10th Dec 20205:35 pmRNSHalf-year Report
22nd Oct 20203:30 pmRNSNotice of AGM
15th Oct 20204:00 pmRNSQuarterly Report
15th Oct 20204:00 pmRNSDividend Declaration
14th Sep 20203:55 pmRNSHolding(s) in Company
30th Jul 20204:34 pmRNSAnnual Financial Report
16th Jul 20203:01 pmRNSQuarterly Report
16th Jul 20203:00 pmRNSDividend Declaration
23rd Apr 202011:00 amRNSPrice Monitoring Extension
21st Apr 202011:30 amRNSQuarterly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.